317 results on '"Eriksen, Erik Fink"'
Search Results
52. The Norwegian Capture the Fracture Initiative a stepped wedge cluster randomized 1 controlled trial of a Fracture Liaison Service model of care: The NoFRACT Trial Protocol
53. Changes in Bone Marrow Adipose Tissue One Year After Roux‐en‐Y Gastric Bypass: A Prospective Cohort Study
54. Leif Mosekilde
55. Consensus development statement on osteoporosis
56. Estrogens and bone
57. B Vitamins and Hip Fracture: Secondary Analyses and Extended Follow-Up of Two Large Randomized Controlled Trials
58. Novel findings in gene expression detected in human osteosarcoma by cDNA microarray
59. Secondary hyperparathyroidism after obesity surgery is associated with serum levels of 25-hydroxyvitamin D and ionized calcium
60. Østrogener i menopausen – på tide å endre anbefalingene?
61. Discovering the difference in the tear fluid proteome between Graves' patients with or without orbitopathy
62. IV. zoledronic acid promotes healing of complicated stress fractures in the foot
63. Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report
64. Clinical updates in hypoparathyroisism
65. Establishment of a tear protein biomarker panel differentiating between Graves’ disease with or without orbitopathy
66. High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis – a randomized controlled trial
67. Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
68. Importance of diet and sex in prevention of coronary artery disease, cancer, osteoporosis, and overweight or underweight: a study of attitudes and practices of Danish primary care physicians
69. Skeletal effects of a gastrin receptor antagonist in H+/K+ATPase beta subunit KO mice
70. Response to letter to the editor by Leder et al. regarding commentary “Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmetics”
71. Commentary: Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmetics
72. Impaired bone material properties increase the risk of all fractures and severity of vertebral fractures in osteoporosis: an impact microindentation study
73. Bone marrow oedema syndrome
74. Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report.
75. Single unit filter-aided method for fast proteomic analysis of tear fluid
76. Re: Femurfraktur og kjeveleddsdestruksjon etter bruk av bisfosfonater
77. Commentary on Sclerostin Deficiency Is Linked to Altered Bone Composition
78. D-vitamin:old paradoxes and new perspectives
79. Bone Tissue— Bone Training
80. Bone marrow lesions are characterized by increased bone turnover and increased vascularity
81. Are the high hip fracture rates among Norwegian women explained by impaired bone material properties?
82. E. Fink Eriksen svarer
83. Characteristics of Glucose Metabolism in Nordic and South Asian Subjects with Type 2 Diabetes
84. Vitamin D deficiency and aging:implications for general health and osteoporosis
85. Osteoporosis in premenopausal women
86. A case of atypical femoral fracture with abnormal cortical bone characterized by impaired mineralization and pyrophosphate accumulation
87. Østrogen og hjerte
88. Excessive Decrease in Serum Magnesium After Total Thyroidectomy for Graves’ Disease Is Related to Development of Permanent Hypocalcemia
89. Bone Turnover and Metabolism in Patients with Early Multiple Sclerosis and Prevalent Bone Mass Deficit: A Population-Based Case-Control Study
90. Bone marrow lesions: a universal bone response to injury?
91. Treatment of osteopenia
92. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis
93. Osteoporotic Fractures Are Associated with an 86-Base Pair Repeat Polymorphism in the Interleukin-1-Receptor Antagonist Gene But Not with Polymorphisms in the Interleukin-1β Gene
94. 1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells
95. Letter to the Editor
96. Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture
97. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
98. Critical review: Updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients—May 2006
99. Effect of once-yearly infusion of zoledronic acid 5mg in postmenopausal women with osteoporosis
100. Long‐Term Control of Bone Turnover in Paget's Disease With Zoledronic Acid and Risedronate
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.